Carregant...
Prostate Cancer Immunotherapy: The Path Forward
PURPOSE OF THIS REVIEW: To provide an overview of current strategies being investigated in the development of immunotherapy in prostate cancer. RECENT FINDINGS: Development of immunotherapy in prostate cancer actually began in 2010 with FDA approval of sipuleucel-T. Given that immune checkpoint inhi...
Guardat en:
| Publicat a: | Curr Opin Support Palliat Care |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8258656/ https://ncbi.nlm.nih.gov/pubmed/28644303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SPC.0000000000000278 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|